Jaguar Animal Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Jaguar Animal's Non Current Liabilities Total is fairly stable compared to the past year. Current Deferred Revenue is likely to rise to about 8.6 M in 2025, whereas Total Assets are likely to drop slightly above 31.9 M in 2025. Key indicators impacting Jaguar Animal's financial strength include:
The financial analysis of Jaguar Animal is a critical element in measuring its lifeblood. Investors should not minimize Jaguar Animal's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the imprecision that can be found in Jaguar Animal's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Jaguar Animal Health. Check Jaguar Animal's Beneish M Score to see the likelihood of Jaguar Animal's management manipulating its earnings.
Jaguar Animal Stock Summary
Jaguar Animal competes with IBio, Common, GeoVax Labs, Ocugen, Zura Bio, and ZyVersa Therapeutics. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California. Jaguar Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 52 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
Cash flow analysis captures how much money flows into and out of Jaguar Animal Health. It measures of how well Jaguar is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Jaguar Animal brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Jaguar had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Jaguar Animal has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
Comparative valuation techniques use various fundamental indicators to help in determining Jaguar Animal's current stock value. Our valuation model uses many indicators to compare Jaguar Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jaguar Animal competition to find correlations between indicators driving Jaguar Animal's intrinsic value. More Info.
Jaguar Animal Health is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Jaguar Animal's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jaguar Animal's earnings, one of the primary drivers of an investment's value.
Jaguar Animal Health Systematic Risk
Jaguar Animal's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Jaguar Animal volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Jaguar Animal Health correlated with the market. If Beta is less than 0 Jaguar Animal generally moves in the opposite direction as compared to the market. If Jaguar Animal Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Jaguar Animal Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Jaguar Animal is generally in the same direction as the market. If Beta > 1 Jaguar Animal moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Jaguar Animal Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Jaguar Animal's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Jaguar Animal growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Jaguar Animal help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Jaguar Animal Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Jaguar Animal Health based on widely used predictive technical indicators. In general, we focus on analyzing Jaguar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Jaguar Animal's daily price indicators and compare them against related drivers.
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.